A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold Sensitivity
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/23/2018 |
| Start Date: | February 1, 2017 |
| End Date: | February 1, 2021 |
| Contact: | Kim Reiss Binder, MD |
| Email: | PennCancerTrials@emergingmed.com |
| Phone: | 855-216-0098 |
The main purpose of this study is to evaluate whether exposure to ice chips in the mouth
(oral ice chips) during oxaliplatin treatment prevents or reduces symptoms of cold
sensitivity.
(oral ice chips) during oxaliplatin treatment prevents or reduces symptoms of cold
sensitivity.
Inclusion Criteria:
- Individuals ≥18 years of age will be enrolled.
- Patients must have histologic confirmation of a solid tumor malignancy that will be
treated with a regimen that contains full-dose oxaliplatin.
- Patients may be receiving treatment in the neoadjuvant, adjuvant or metastatic
setting.
- Patients must be treatment-naïve to platinum-agents at the time of enrollment. Prior
treatment with non-platinum agents is permitted.
Exclusion Criteria:
- Any active intraoral infection, including yeast infection (thrush) or active oral
herpes simplex virus at the time of enrollment.
- Patients may not have dentures.
- Patients may not have a disorder that may result in altered taste sensation at
baseline. This includes but is not limited to: persistent dry mouth.
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065
Principal Investigator: Kim Reiss Binder, MD
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials
